Beta Bionics, Inc. · NASDAQ:BBNX

Dapice Joshua J. reported a 9.90% stake in Beta Bionics, Inc. (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 9, 2026

Dapice Joshua J. reported a 9.90% stake in Beta Bionics, Inc., 4,379,920 shares, as a passive investor on Dec 31, 2025. Filed Feb 9, 2026 (Schedule 13G/A).

Stake
9.90%
Shares
4,379,920
Intent
Passive
What changed
Stake changed
Filed together
31 holders

The filing in full

HolderStakeShares
Zone Healthcare Holdings, LLC7.40%3,277,220
Farallon Capital Partners, L.P.0.50%198,706
Farallon Capital Institutional Partners, L.P.0.50%212,605
Farallon Capital Institutional Partners II, L.P.0.20%73,147
Farallon Capital Institutional Partners III, L.P.0.10%49,965
Four Crossings Institutional Partners V, L.P.0.10%49,357
Farallon Capital Offshore Investors II, L.P.1.00%446,621
Farallon Capital (AM) Investors, L.P.0.10%29,738
Farallon Capital F5 Master I, L.P.0.10%42,561
Farallon Capital Management, L.L.C.7.40%3,277,220
Farallon Partners, L.L.C.2.40%1,060,139
Farallon F5 (GP), L.L.C.0.10%42,561
Farallon Institutional (GP) V, L.L.C.0.10%49,357
Dapice Joshua J.9.90%4,379,920
Dreyfuss, Philip D.9.90%4,379,920
Dunn Hannah E.9.90%4,379,920
Fried, Richard B0%0
Gehani, Varun N.9.90%4,379,920
Giauque, Nicolas9.90%4,379,920
Husen, Avner A.9.90%4,379,920
Kim, David T.9.90%4,379,920
Linn, Michael G.9.90%4,379,920
Luo Patrick (Cheng)9.90%4,379,920
Patel, Rajiv A.0%0
Roberts, Jr., Thomas G.9.90%4,379,920
Saito Edric C.9.90%4,379,920
Seybold, William0%0
Short Daniel S.9.90%4,379,920
Spokes, Andrew J. M.9.90%4,379,920
Warren, John R.9.90%4,379,920
Wehrly, Mark C.9.90%4,379,920

Source

View original at SEC

Related